California Public Employees Retirement System Rigel Pharmaceuticals Inc Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.09 - $4.54 $1.07 Million - $1.57 Million	-344,900 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$3.35 - $4.93 $106,724 - $157,059	-31,858 Reduced 8.46%	344,900 $1.18 Million
Q4 2020 Feb 02, 2021	SELL	$2.35 - $3.74 $17,155 - $27,302	-7,300 Reduced 1.9%	376,758 $1.32 Million
Q3 2020 Nov 05, 2020	BUY	$1.78 - $4.13 $14,952 - $34,692	8,400 Added 2.24%	384,058 $922,000
Q2 2020 Aug 12, 2020	BUY	$1.41 - $2.05 $1,128 - $1,639	800 Added 0.21%	375,658 $687,000
Q1 2020 May 12, 2020	SELL	$1.27 - $3.0 $133,096 - $314,400	-104,800 Reduced 21.85%	374,858 $585,000
Q4 2019 Jan 27, 2020	SELL	$1.6 - $2.43 $71,680 - $108,864	-44,800 Reduced 8.54%	479,658 $1.03 Million
Q3 2019 Oct 31, 2019	BUY	$1.63 - $2.62 $95,938 - $154,207	58,858 Added 12.64%	524,458 $981,000
Q2 2019 Aug 15, 2019	SELL	$2.02 - $2.61 $29,088 - $37,584	-14,400 Reduced 3.0%	465,600 $1.22 Million
Q4 2018 Feb 08, 2019	SELL	$2.08 - $3.36 $58,435 - $94,395	-28,094 Reduced 5.53%	480,000 $1.1 Million
Q3 2018 Nov 13, 2018	SELL	$2.6 - $3.59 $110,760 - $152,934	-42,600 Reduced 7.74%	508,094 $1.63 Million
Q2 2018 Aug 15, 2018	SELL	$2.83 - $4.11 $936,180 - $1.36 Million	-330,806 Reduced 37.53%	550,694 $1.56 Million
Q3 2017 Nov 15, 2017	BUY	$2.18 - $2.57 $1.92 Million - $2.27 Million	881,500	881,500 $2.24 Million

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account